Arrowhead Pharmaceuticals (NASDAQ:ARWR) Shares Gap Up Following Analyst Upgrade theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Arrowhead Pharmaceuticals Closes Underwritten Offering with Gross Proceeds of $450 0 Million streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Arrowhead Pharmaceuticals, Inc. today announced that on January 5, 2024, it closed the previously announced underwritten registered offering of 15,790,000 shares of its common stock, par value.
U.S. stocks traded mostly higher, with the Dow Jones index gaining around 150 points on Thursday. Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose during Thursday’s session following better-than-expected quarterly results.
Arrowhead Pharmaceuticals, Inc. today announced the pricing of an underwritten registered offering of 15,790,000 shares of its common stock, par value $0.001 per share , offered at a price of $28.50.